Application 074182
- Type
- ANDA
- Sponsor
- PLIVA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NAPROXEN | NAPROXEN | TABLET;ORAL | 250MG | No | No |
| 002 | NAPROXEN | NAPROXEN | TABLET;ORAL | 375MG | No | No |
| 003 | NAPROXEN | NAPROXEN | TABLET;ORAL | 500MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074182-001 | NAPROXEN | NAPROXEN | 250MG | TABLET / ORAL | 1996-06-27 | ||
| A074182-002 | NAPROXEN | NAPROXEN | 375MG | TABLET / ORAL | 1996-06-27 | ||
| A074182-003 | NAPROXEN | NAPROXEN | 500MG | TABLET / ORAL | 1996-06-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A074182-001 | NAPROXEN | 250MG | TABLET / ORAL | 1996-06-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A074182-002 | NAPROXEN | 375MG | TABLET / ORAL | 1996-06-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A074182-003 | NAPROXEN | 500MG | TABLET / ORAL | 1996-06-27 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A074182-001 | NAPROXEN | 250MG | TABLET / ORAL | 1996-06-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A074182-002 | NAPROXEN | 375MG | TABLET / ORAL | 1996-06-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A074182-003 | NAPROXEN | 500MG | TABLET / ORAL | 1996-06-27 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A074182-001 | NAPROXEN | 250MG | TABLET / ORAL | 1996-06-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A074182-002 | NAPROXEN | 375MG | TABLET / ORAL | 1996-06-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A074182-003 | NAPROXEN | 500MG | TABLET / ORAL | 1996-06-27 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A074182-001 | NAPROXEN | 250MG | TABLET / ORAL | 1996-06-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A074182-002 | NAPROXEN | 375MG | TABLET / ORAL | 1996-06-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A074182-003 | NAPROXEN | 500MG | TABLET / ORAL | 1996-06-27 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A074182-001 | NAPROXEN | 250MG | TABLET / ORAL | 1996-06-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A074182-002 | NAPROXEN | 375MG | TABLET / ORAL | 1996-06-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A074182-003 | NAPROXEN | 500MG | TABLET / ORAL | 1996-06-27 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A074182-001 | NAPROXEN | 250MG | TABLET / ORAL | 1996-06-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A074182-002 | NAPROXEN | 375MG | TABLET / ORAL | 1996-06-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A074182-003 | NAPROXEN | 500MG | TABLET / ORAL | 1996-06-27 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A074182-001 | NAPROXEN | 250MG | TABLET / ORAL | 1996-06-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A074182-002 | NAPROXEN | 375MG | TABLET / ORAL | 1996-06-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A074182-003 | NAPROXEN | 500MG | TABLET / ORAL | 1996-06-27 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A074182-001 | NAPROXEN | 250MG | TABLET / ORAL | 1996-06-27 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A074182-002 | NAPROXEN | 375MG | TABLET / ORAL | 1996-06-27 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A074182-003 | NAPROXEN | 500MG | TABLET / ORAL | 1996-06-27 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A074182-001 | NAPROXEN | 250MG | TABLET / ORAL | 1996-06-27 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A074182-002 | NAPROXEN | 375MG | TABLET / ORAL | 1996-06-27 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A074182-003 | NAPROXEN | 500MG | TABLET / ORAL | 1996-06-27 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A074182-001 | NAPROXEN | 250MG | TABLET / ORAL | 1996-06-27 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A074182-002 | NAPROXEN | 375MG | TABLET / ORAL | 1996-06-27 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A074182-003 | NAPROXEN | 500MG | TABLET / ORAL | 1996-06-27 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A074182-001 | NAPROXEN | 250MG | TABLET / ORAL | 1996-06-27 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A074182-002 | NAPROXEN | 375MG | TABLET / ORAL | 1996-06-27 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A074182-003 | NAPROXEN | 500MG | TABLET / ORAL | 1996-06-27 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A074182-001 | NAPROXEN | 250MG | TABLET / ORAL | 1996-06-27 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A074182-002 | NAPROXEN | 375MG | TABLET / ORAL | 1996-06-27 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A074182-003 | NAPROXEN | 500MG | TABLET / ORAL | 1996-06-27 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A074182-001 | NAPROXEN | 250MG | TABLET / ORAL | 1996-06-27 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A074182-002 | NAPROXEN | 375MG | TABLET / ORAL | 1996-06-27 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A074182-003 | NAPROXEN | 500MG | TABLET / ORAL | 1996-06-27 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A074182-001 | NAPROXEN | 250MG | TABLET / ORAL | 1996-06-27 | 301d65b070ca… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | fa2fe6fd-c476-dd29-e053-6294a90a9e9e | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | Naproxen NAPROXEN |
| Naproxen | NAPROXEN | Northwind Health Company, LLC | 0de6d673-fa76-e9c0-e063-6394a90a9ded | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Naproxen NAPROXEN |
| NAPROXEN | NAPROXEN | Northwind Health Company, LLC | f32d755e-4984-ee40-e053-2995a90a4ebe | 2026-01-01 | Warnings | NAPROXEN NAPROXEN |
| Naproxen | NAPROXEN | Northwind Health Company, LLC | fb07a76b-98ce-85dd-e053-6294a90aa6a8 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Naproxen NAPROXEN |
| Naproxen | NAPROXEN | Northwind Health Company, LLC | ab6ec2c9-5df9-346c-e053-2a95a90ac81d | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Naproxen NAPROXEN |
| Naproxen | NAPROXEN | Northwind Health Company, LLC | db478961-d984-7c8e-e053-2995a90a8a12 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Naproxen NAPROXEN |
| Naproxen | NAPROXEN | Northwind Health Company, LLC | c986ba9a-6f48-8347-e053-2a95a90aa1c1 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | Naproxen NAPROXEN |
| Naproxen | NAPROXEN | QPharma, Inc. | 307aa67f-53b9-4c60-a328-091bbf6338d4 | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | Naproxen NAPROXEN |
| Naproxen Sodium | NAPROXEN SODIUM | Glenmark Pharmaceuticals Inc., USA | 6c5bb008-e66f-4ef0-bf84-aca7eb5983e9 | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | Naproxen NAPROXEN |
| Naproxen | NAPROXEN | Safeway, Inc | f2a273f8-d623-dc2f-e053-2995a90a0c02 | 2025-12-19 | Warnings | Naproxen NAPROXEN |
| Naproxen | NAPROXEN | Sunrise Pharmaceutical, Inc. | f2fb222a-b854-4e6f-9027-2e08aed24185 | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | Naproxen NAPROXEN |
| Naproxen | NAPROXEN | Granules Pharmaceuticals Inc. | c1cb9bb9-fbae-5e5c-e053-2995a90a0d21 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | Naproxen NAPROXEN |
| NAPROXEN | NAPROXEN | QPharma Inc | c0a4839b-7154-c82c-e053-2a95a90a7e6d | 2025-12-03 | Warnings | NAPROXEN NAPROXEN |
| Naproxen | NAPROXEN SODIUM | Granules India Ltd | 1f8da545-bcfe-4c22-a9f1-d34108120aa0 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | Naproxen |
| Naproxen | NAPROXEN | PHOENIX RX LLC | 43912294-77c9-eda8-e063-6394a90adf0a | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | Naproxen NAPROXEN |
| Naproxen | NAPROXEN | A-S Medication Solutions | 8c3398bd-66b1-4a14-8aaa-e4a2d6749a08 | 2025-11-02 | Boxed warning, Warnings, Adverse reactions | Naproxen NAPROXEN |
| Naproxen | NAPROXEN SODIUM | Better Living Brands, LLC | 43745d42-f859-4168-a2dd-2c8ae47ae590 | 2025-10-28 | Warnings | Naproxen |
| Naproxen | NAPROXEN | Medcore LLC | 129392c8-8ce1-4b78-8863-042db880095f | 2025-10-28 | Boxed warning, Warnings, Adverse reactions | Naproxen NAPROXEN |
| Naproxen | NAPROXEN SODIUM | Family Dollar Services Inc | b6205032-f5c6-494a-8b87-adbbbc3982e7 | 2025-10-27 | Warnings | Naproxen |
| Naproxen | NAPROXEN SODIUM | Amerisource Bergen | 1e2e6e3a-b095-4d5b-86fe-61eb44a87cf0 | 2025-10-20 | Warnings | Naproxen |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.